Parambir Singh Dulai

Northwestern University

NIH Rank #1923
  • Program Leader
  • R01 Holder
  • Top 10% Funded
  • Early Career
  • Diverse Portfolio

NIH Funding · FY2024

Total Funding
$3.6M
Fiscal year 2024
Grants Awarded
3
Active NIH grants
National Rank
#1,923
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $3.6M across 3 grants · National rank #1923.

Top grants by award amount

Parambir Singh Dulai's NIH grant portfolio, ranked by award amount.

  • 5U01DK134321-02U01
    Hyperbaric Oxygen Therapy for Ulcerative Colitis Patients Hospitalized for Moderate to Severe Flares: A Phase 3 Multi-Center, Randomized, Double-Blind, Sham-Controlled Trial
    $2.4M
    award amount
  • 5R01DK135620-02R01
    Identifying Neutrophil Specific Mechanisms for Resistance to Biologics in Ulcerative Colitis
    $655.5K
    award amount
  • 1U19AI181102-01U19
    The Neu-Lung Consortium: Neutrophilic Mechanisms of Inflammation, Injury, and Repair in Lung and Airways Diseases
    $588.4K
    award amount

Affiliation

Institutions that have administered grants for Parambir Singh Dulai.

Affiliated with Northwestern University (IL).

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Northwestern University
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #1923
  6. 2024
    Entered Top 25% Nationally
    Ranked #1923
  7. 2024
    Entered Top 10% Nationally
    Ranked #1923